<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-22604-2S4KN</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">The FIND study: core-needle biopsies to detect the hidden HIV reservoirs in hard-to-reach tissue compartments of well-controlled and uncontrolled HIV-patients</narrative>
  </title>
  <description type="4">
   <narrative xml:lang="EN">Isolated cases of an HIV cure (Berlin Patient) and the short- and long-term control of HIV infection (Mississippi baby, Boston patients, Visconti cohort) have galvanized the HIV research community into trying to gain a better understanding of persistent HIV reservoirs. The different viral reservoirs all represent their own unique microenvironment affected by localized immune pressures, cell type-specific differences in replication and cell/tissue-specific penetration of antiretroviral drugs and/or selection of drug resistance. Since these viral reservoirs represent the major obstacle to viral eradication and are difficult if not impossible to sample while patients are alive, we propose a rapid in-depth post-mortem analysis using minimally-invasive fine-needle biopsies.</narrative>
  </description>
  <description type="3">
   <narrative xml:lang="EN">No patients will be directly affected by this study.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">The major obstacle to an HIV cure is the presence of a persistent viral reservoir of latently-infected cells. Yet many basic questions about the location and composition of viral reservoirs remain unanswered. In this study we will determine whether minimally-invasive fine-needle biopsies can be used to investigate the viral reservoirs in hard-to-reach tissue compartments of HIV infected patients within hours of death. Ten HIV-infected patients (5 on ART) will be enrolled, and multiple fine-needle biopsies on 15 target organs will be performed. HIV-DNA will be quantified and the viral population will be characterized. The outcome of this study will provide novel insights into HIV reservoirs and reservoir dynamics in response to ART, and will help to target future HIV eradication strategies.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">This study is designed to test the feasibility of investigating the HIV reservoir via post-mortem fine-needle biopsies. If the approach is successful and sufficient levels of viral DNA can be detected, in-depth viral and cellular characterization can be performed. This will provide insight into the presence and dynamics of the persisting viral reservoirs despite successful antiretroviral therapy, which will be extremely relevant for eradication studies. 
The study-specific outcomes include: 1) the feasibility of the fine-needle approach to analysing the size and cellular composition of remaining reservoirs, 2) the quantification of HIV DNA in these cellular reservoirs, and 3) sample repository.</narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-30244197" role="4" type="80">
   <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2017-09-15" type="1"></activity-date>
  <activity-date iso-date="2019-06-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
   </organisation>
   <telephone>+31(0)206262669</telephone>
   <email>IATI@aidsfonds.nl</email>
  </contact-info>
  <recipient-country code="NL" percentage="100"></recipient-country>
  <location>
   <name>
    <narrative xml:lang="EN">Utrecht</narrative>
   </name>
  </location>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">The FIND study: core-needle biopsies to detect the hidden HIV reservoirs in hard-to-reach tissue compartments of well-controlled and uncontrolled HIV-patients STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="3"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2017-09-15"></period-start>
   <period-end iso-date="2019-06-01"></period-end>
   <value currency="EUR" value-date="2017-09-15">73511</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-28"></transaction-date>
   <value currency="EUR" value-date="2017-12-28">66160</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-12-28"></transaction-date>
   <value currency="EUR" value-date="2017-12-28">66160</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-02-24"></transaction-date>
   <value currency="EUR" value-date="2020-02-24">7351</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-24"></transaction-date>
   <value currency="EUR" value-date="2020-02-24">7351</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
 </iati-activity>
</iati-activities>
